¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"alveolar macrophage elastase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • macrophage-derived growth factor
    Å«Æ÷½Ä¼¼Æ÷À¯·¡¼ºÀåÀÎÀÚ, ´ë½Ä¼¼Æ÷À¯·¡¼ºÀåÀÎÀÚ
  • resident macrophage
    »óÁÖÅ«Æ÷½Ä¼¼Æ÷, »óÁÖ´ë½Ä¼¼Æ÷
  • alveolar
    1. ÇãÆÄ²Ê¸®-, ÆóÆ÷- 2. ÀÌÆ²-, Ä¡Á¶-
  • alveolar abscess
    ÀÌÆ²°í¸§Áý, Ä¡Á¶³ó¾ç
  • alveolar adenoma
    ²Ê¸®»ùÁ¾
  • alveolar arch
    ÀÌÆ²È°, Ä¡Á¶±Ã
  • alveolar artery
    ÀÌÆ²µ¿¸Æ, Ä¡Á¶µ¿¸Æ
  • alveolar atrium
    ÇãÆÄ²Ê¸®¹æ, ÆóÆ÷¹æ
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
  • alveolar base
    ÀÌÆ²¹Ù´Ú, Ä¡Á¶±âÀú
  • alveolar bone
    ÀÌÆ²»À, Ä¡Á¶°ñ
  • alveolar bone graft
    ÀÌÆ²»ÀÀ̽Ä, Ä¡Á¶°ñÀ̽Ä
  • alveolar bud
    ²Ê¸®½Ï
  • alveolar canal
    ÀÌÆ²°ü, Ä¡Á¶°ü
  • alveolar clearance
    ÇãÆÄ²Ê¸®Ã»¼Ò, ÆóÆ÷û¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • macrophage system
    Å«Æ÷½Ä¼¼Æ÷°èÅë
  • macrophage migration test
    Å«Æ÷½Ä¼¼Æ÷À̵¿°Ë»ç
  • monocyte-macrophage cell system
    ´ÜÇÙ±¸Å«Æ÷½Ä¼¼Æ÷°èÅë
  • resident macrophage
    Åä¹ÚÀÌÅ«Æ÷½Ä¼¼Æ÷
  • alveolar
    ²Ê¸®-, ÀÌÆ²-, Ä¡Á¶-
  • alveolar base
    ÀÌÆ²¹Ù´Ú, Ä¡Á¶±âÀú
  • alveolar bone
    ÀÌÆ²»À
  • alveolar bud
    ²Ê¸®½Ï
  • alveolar canal
    ÀÌÆ²°ü
  • alveolar clearance
    ÆóÆ÷û¼Ò
  • alveolar cleft
    ÀÌÆ²Æ´»õ, Ä¡Á¶¿­
  • alveolar duct
    ÇãÆÄ²Ê¸®°ü, ÆóÆ÷°ü
  • alveolar fiber
    ÀÌÆ²¼¶À¯
  • alveolar fistula
    ÀÌÆ²»û±æ, Ä¡Á¶·ç
  • alveolar foramen
    ÀÌÆ²±¸¸Û
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • alveolar abscess
    Ä¡Á¶³ó¾ç(¡­ÒÛåË).
  • alveolar abscess
    Ä¡Á¶³ó¾ç(öÍðËÒÛåË)
  • alveolar adenoma
    Æ÷»ó¼±Á¾(øàßÒàÍðþ).
  • alveolar adventitious dentin
    ºÀ¼Ò»ó ¿ì¼º »ó¾ÆÁú(ÜðáµßÒéÏà÷ßÚä³òõ).
  • alveolar anoxia
    ÆóÆ÷¼º ¹«»ê¼Ò(Áõ)(øËøààõÙíß«áÈñø).
  • alveolar arch
    ÀÌÆ²È°
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷.
  • alveolar asthma
    ÆóÆ÷¼º õ½Ä(øËøààõô·ãÓ).
  • alveolar atrium
    ÇãÆÄ²Ê¸®¹æ
  • alveolar atrophy<³ª> atrophia alveolaris
    Ä¡Á¶À§Ãà(öÍðËê×õê).
  • alveolar base
    Ä¡Á¶±âÀú(öÍðËÐñî¼).
  • alveolar blennorrhea
    Ä¡ÁÖ¿°(öÍñ²æú).
  • alveolar bone
    ÀÌÆ²»À
  • alveolar border =a. margin
    Ä¡Á¶¿¬(öÍðËæÞ).
  • alveolar branches
    Ä¡Á¶Áö »ó¾Ç½Å°æ(ß¾äÉãêÌè)ÀÇ .
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intra-epidermal macrophage
    Ç¥ÇǼÓÅ«Æ÷½Ä¼¼Æ÷
  • macrophage
    ´ë½Ä¼¼Æ÷(ÓÞãÝá¬øà), ´ë½Ä±¸.
  • macrophage
    Å«Æ÷½Ä¼¼Æ÷
  • macrophage
    ´ë½Ä¼¼Æ÷(ÓÞãÝá¬øà), ´ë½Ä±¸(¡­Ï¹)
  • macrophage activating factor (MAF)
    ´ë½Ä¼¼Æ÷ Ȱ¼ºÀÎÀÚ
  • macrophage aggregating factor
    ´ë½Ä¼¼Æ÷ °áÁýÀÎÀÚ
  • macrophage arming factor
    ´ë½Ä¼¼Æ÷ ¹«ÀåÀÎÀÚ
  • macrophage chemotactic and activating factor
    ´ë½Ä¼¼Æ÷ ÁÖÈ­ ¹× Ȱ¼º ÀÎÀÚ
  • macrophage chemotactic factor (MCF)
    ´ë½Ä¼¼Æ÷ È­ÇÐÁÖ¼ºÀÎÀÚ
  • macrophage colony-stimulating factor(M-CSF)
    ´ë½Ä¼¼Æ÷ Áý¶ô ÀÚ±ØÀÎÀÚ
  • macrophage cytophilic antibody
    ´ë½Ä¼¼Æ÷ģȭÇ×ü(ÓÞãÝá¬øàöÑûúù÷ô÷).
  • macrophage formation
    ´ë½Ä¼¼Æ÷ Çü¼º
  • macrophage migration inhibition factor(mif)
    ´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ (MIF) (¡­ë´ñËîÁò­ì×í­)
  • macrophage migration inhibition test
    ´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁö½ÃÇè.
  • macrophage migration inhibitory factor
    ´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Inferior alveolar nerve
    ¾Æ·¡ÀÌÆ²½Å°æ
    [¿¾ ¿ë¾î] ÇÏÄ¡Á¶½Å°æ
  • Anterior superior alveolar branches
    ¾ÕÀ§ÀÌÆ²°¡Áö
    [¿¾ ¿ë¾î] Àü»óÄ¡Á¶Áö
  • Anterior superior alveolar arteries
    ¾ÕÀ§ÀÌÆ²µ¿¸Æ
    [¿¾ ¿ë¾î] Àü»óÄ¡Á¶µ¿¸Æ
  • Superior alveolar nerves
    À§ÀÌÆ²½Å°æ
    [¿¾ ¿ë¾î] »óÄ¡Á¶½Å°æ
  • Alveolar canal
    ÀÌÆ²°ü
    [¿¾ ¿ë¾î] Ä¡Á¶°ü
  • Alveolar foramina
    ÀÌÆ²±¸¸Û
    [¿¾ ¿ë¾î] Ä¡Á¶°ø
  • Alveolar process
    ÀÌÆ²µ¹±â
    [¿¾ ¿ë¾î] Ä¡Á¶µ¹±â
  • Alveolar part
    ÀÌÆ²ºÎºÐ
    [¿¾ ¿ë¾î] Ä¡Á¶ºÎ
  • Alveolar bone
    ÀÌÆ²»À
    [¿¾ ¿ë¾î] Ä¡Á¶°ñ
  • Alveolar periosteum
    ÀÌÆ²»À(¹Ù±ù)¸·
    [¿¾ ¿ë¾î] Ä¡Á¶¸·
  • Alveolar yokes
    ÀÌÆ²À¶±â
    [¿¾ ¿ë¾î] Ä¡Á¶À¶±â
  • Alveolar arch
    ÀÌÆ²È°
    [¿¾ ¿ë¾î] Ä¡Á¶±Ã
  • Lactiferous alveolar duct
    Á¥»ù²Ê¸®°ü
    [¿¾ ¿ë¾î] À¯Æ÷»ó°ü
  • Middle superior alveolar branch
    Áß°£À§ÀÌÆ²°¡Áö
    [¿¾ ¿ë¾î] Áß»óÄ¡Á¶Áö
  • Alveolar duct
    ÇãÆÄ²Ê¸®°ü
    [¿¾ ¿ë¾î] ÆóÆ÷°ü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AMDGF alveolar macrophage-derived growth factor
HAM hearing aid microphone; helical axis in motion; human albumin microsphere; human alveolar macrophage...
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
EIC elastase inhibition capacity; enzyme inhibition complex
El elastase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
G-E Granulocyte elastase
HLE Human Leukocyte Elastase
HNE Human neutrophil elastase
NE Neutrophil elastase
PMNE Polymorphonuclear Elastase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼Ò ºÐ¾ÐÂ÷
  • alveolar atrophy
    Ä¡Á¶ À§Ãà
  • alveolar base
    Ä¡Á¶ ±âÀú
  • alveolar bone
    Ä¡Á¶°ñ
    Ä¡±ÙÀÌ À§Ä¡ÇÏ´Â »ó¾Ç°ú ÇϾÇÀÇ °ñ ºÎºÐ.
  • alveolar bone graft
    Ä¡Á¶°ñ À̽Ä, Ä¡Á¶°ñ À̽ļú
  • alveolar border
    Ä¡Á¶ ¿¬
  • alveolar canal
    Ä¡Á¶ °ü
  • alveolar cell carcinoma
    ÆóÆ÷ ¼¼Æ÷ ¾ÏÁ¾
  • alveolar crest
    Ä¡Á¶Á¤
  • alveolar cyst
    Ä¡Á¶ ³¶Æ÷
  • alveolar dilution factor
    ÆóÆ÷ Èñ¼® ÀÎÀÚ
  • alveolar equation
    ÆóÆ÷ ¹æÁ¤½Ä
  • alveolar flooding
    ÆóÆ÷ È«¼ö
  • alveolar forcep
    Ä¡Á¶ °âÀÚ
  • alveolar gas equation
    ÆóÆ÷ ±âü ¹æÁ¤½Ä
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
macrophage migration-inhibitory factors Proteins released by sensitised lymphocytes and possibly other cells that inhibit the migration of macrophages away from the release site. The structure and chemical properties may vary with the species and type of releasing cell.
(12 Dec 1998)
receptors, granulocyte-macrophage colony-stimulating factor Receptors that bind and internalise the granulocyte-macrophage stimulating factor. Their mw is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.
(12 Dec 1998)
receptors, macrophage colony-stimulating factor Glycoproteins of mw 165 kD which are encoded by the c-fms proto-oncogene. The binding of csf-1 to its receptors activates an intrinsic tyrosine kinase activity resulting in autophosphorylation of the receptors on tyrosine, rapid receptor down-regulation, and phosphorylation of as yet unidentified physiologic substrates that initiate a mitogenic response.
(12 Dec 1998)
chemotactic factors, macrophage Cytotaxins liberated from normal or invading cells that specifically attract macrophages. They may be lymphokines, products of antigen, antibody and complement interactions or other.
(12 Dec 1998)
granulocyte-macrophage colony-stimulating factor <growth factor, haematology, oncology> An acidic glycoprotein of mw 23 kD with internal disulfide bonds.
It is produced in response to a number of inflammatory mediators by mesenchymal cells present in the haemopoietic environment and at peripheral sites of inflammation.
It stimulates the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from foetal liver progenitor cells. It also has some functional activities in mature granulocytes and macrophages.
It is used to promote the recovery of the white blood cells following chemotherapy.
Chemical name: Colony-stimulating factor 2
See: colony-stimulating factor.
Acronym: GM-CSF
(12 Dec 1998)
wandering macrophage <haematology> A macrophage that leaves the blood and migrates to infected tissue.
(09 Oct 1997)
Hansemann macrophage Large histiocytes with abundant cytoplasm that may contain Michaelis-Gutmann bodies and one or several nuclei; described in lesions of malacoplakia.
(05 Mar 2000)
inflammatory macrophage A macrophage found at sites of inflammation.
(05 Mar 2000)
fixed macrophage A relatively immotile macrophage found in connective tissue, lymph nodes, spleen, and bone marrow.
Synonym: resting wandering cell.
(05 Mar 2000)
free macrophage An actively motile macrophage typically found in sites of inflammation.
(05 Mar 2000)
adenocarcinoma, bronchiolo-alveolar A carcinoma thought to be derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent.
(12 Dec 1998)
alveolar <anatomy> Of, pertaining to, or resembling, alveoli or little cells, sacs, or sockets. Alveolar processes, the processes of the maxillary bones, containing the sockets of the teeth.
Origin: L. Alveolus a small hollow or cavity: cf. F. Alveolaire.
Source: Websters Dictionary
(01 Mar 1998)
alveolar abscess A pocket of pus adjacent to or within (apical abscess) the tooth's root caused by plaque and calculus invasion.
Symptoms include tooth pain and tenderness that may be accompanied by facial swelling and a fever.
Treatment includes antibiotics and a thorough cleansing of the infected site by a dentist.
See: apical abscess.
(27 Sep 1997)
alveolar adenocarcinoma <tumour> Adenocarcinoma of the lung in which tumour cells form structures resembling alveoli.
(05 Mar 2000)
alveolar air The gas in the pulmonary alveoli, where O2-CO2 exchange with pulmonary capillary blood occurs.
Synonym: alveolar air.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á